Madrigal Pharmaceuticals Inc
(MDGL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 79,088 | -92,618 | -63,495 | -57,270 | -68,863 |
| Depreciation Amortization | 2,463 | 2,717 | 3,351 | 3,655 | 2,455 |
| Accounts receivable | 16,000 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -5,668 | 7,134 | -144 | -729 | 476 |
| Other Working Capital | -112,940 | 44,390 | 81,949 | -4,161 | 266 |
| Other Operating Activity | -5,753 | 438 | 5,561 | 5,520 | 3,784 |
| Operating Cash Flow | $-26,810 | $-37,939 | $27,222 | $-52,985 | $-61,882 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 21,503 | -21,503 | 13,135 | 25,154 | 44,059 |
| PPE Investments | -454 | -2,184 | -2,350 | -1,580 | -4,883 |
| Investing Cash Flow | $21,049 | $-23,687 | $10,785 | $23,574 | $39,176 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -2,179 | -2,787 | -2,617 | -2,086 | -1,100 |
| Common Stock Issued | 50 | 1 | 44,796 | 2 | 134 |
| Common Stock Repurchased | N/A | N/A | -290 | N/A | N/A |
| Other Financing Activity | 0 | 880 | 1,994 | 41,373 | 4,745 |
| Financing Cash Flow | $-2,129 | $-1,906 | $43,883 | $39,289 | $3,779 |
| Beginning Cash Position | 52,045 | 115,577 | 33,687 | 23,809 | 42,736 |
| End Cash Position | 44,155 | 52,045 | 115,577 | 33,687 | 23,809 |
| Net Cash Flow | $-7,890 | $-63,532 | $81,890 | $9,878 | $-18,927 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,810 | -37,939 | 27,222 | -52,985 | -61,882 |
| Capital Expenditure | -454 | -2,184 | -2,350 | -1,580 | -4,883 |
| Free Cash Flow | -27,264 | -40,123 | 24,872 | -54,565 | -66,765 |